| Document Date: 2012-11-20 11:06:00
Open Document File Size: 351,50 KBShare Result on Facebook
Company Amarantus Biosciences / / Currency USD / / Event FDA Phase / Funding / Debt Financing / / Facility San Diego State University Heart Institute / / IndustryTerm treatment for neurological disorders / treatment for Parkinson's disease / / MedicalCondition Parkinson's disease / ischemia-reperfusion heart injury / injury / ischemiareperfusion injury / Parkinson’s Disease / ischemia-reperfusion injury / disease / neurological disorders / resultant inflammatory response causes / injuries / / Organization San Diego State University Heart Institute / / Person John W. Commissiong / Team / Gerald E. Commissiong / Robert L. Harris / / Position candidate in development / model / whereas GDNF did not / Independent Director / President & CEO Board of Directors / Executive / / Product MANF / / Technology drug discovery / /
SocialTag |
Amarantus Biosciences [AMBS] RESEARCH Amarantus BioSciences Reports Key Data in Parkinson’s Disease and Ischemia Amarantus